• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克隆、表达及酶活性分析两种新型 CANT1 突变:二聚化的缺失可能提示蛋白构象发生改变,甚至功能丧失。

Cloning, expression and enzyme activity delineation of two novel CANT1 mutations: the disappearance of dimerization may indicate the change of protein conformation and even function.

机构信息

Medical Genetic Institute of Henan Province, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, 450003, People's Republic of China.

National Health Commission Key Laboratory of Birth Defects Prevention, Henan Key Laboratory of Population Defects Prevention, Henan Institute of Reproduction Health Science and Technology, Zhengzhou, 450014, People's Republic of China.

出版信息

Orphanet J Rare Dis. 2020 Sep 9;15(1):240. doi: 10.1186/s13023-020-01492-8.

DOI:10.1186/s13023-020-01492-8
PMID:32907608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7487677/
Abstract

BACKGROUND

Desbuquois dysplasia (DBQD) was a rare autosomal recessive skeletal dysplasia. Calcium activated nucleotidase 1 (CANT1) mutation was identified as a common pathogenic change for DBQD type 1 and Kim variant but not for DBQD type 2. To our knowledge, all patients with DBQD type 1 currently found could be explained by mutations in the CANT1 gene, but mutations in the CANT1 gene might not be directly diagnosed as DBQD type 1.

RESULTS

We have identified two novel CANT1 mutations (mut1: c.594G > A [p.Trp198*], mut2: c.734C > T [p.Pro245Leu]) in three children from a family of Chinese origin for the first time. Two of the three children could be diagnosed as typical DBQD type 1 and one child could not be diagnosed as DBQD type 1 based on the clinical data we had. To further clarify the effect of the two mutations of the CANT1 gene, we studied the CANT1 gene expression and detected the protein secretion and nucleotide enzyme activity through cDNA cloning and expression vectors construction for wild and mutant types. The mut1 was a nonsense mutation which could lead to premature termination and produced the truncated bodies; The CANT1 dimer of mut2 was significantly reduced and even undetectable. The extracellular secretion of mut1 was extremely high while mut2 was significantly reduced compared with the wild type. And mut1 and mut2 also could result in a significant reduction in the activity of CANT1 nucleotidease. From the results we could deduce that the two mutations of the CANT1 gene were the causes of the two cases in this study.

CONCLUSIONS

Regarding the particularity of the cases reported in this study, the pathogenesis of CANT1 might be more complicated. The genetic and phenotype of three children with the same genetic background need to be further studied. Larger cohort of patients was needed to establish genotype-phenotype correlations in DBQD.

摘要

背景

Desbuquois 发育不良(DBQD)是一种罕见的常染色体隐性骨骼发育不良。钙激活核苷酸酶 1(CANT1)突变被确定为 DBQD 1 型和 Kim 变异型的常见致病变化,但不是 DBQD 2 型的致病变化。据我们所知,目前发现的所有 DBQD 1 型患者都可以用 CANT1 基因突变来解释,但 CANT1 基因突变可能不能直接诊断为 DBQD 1 型。

结果

我们首次在一个华裔家庭的 3 名儿童中发现了 2 种新的 CANT1 突变(mut1:c.594G > A [p.Trp198*],mut2:c.734C > T [p.Pro245Leu])。这 3 名儿童中的 2 名可被诊断为典型的 DBQD 1 型,而根据我们所掌握的临床资料,1 名儿童不能被诊断为 DBQD 1 型。为了进一步阐明 CANT1 基因突变的影响,我们通过 cDNA 克隆和表达载体构建研究了 CANT1 基因的表达,并检测了突变型和野生型 CANT1 蛋白的分泌和核苷酸酶活性。mut1 是一种无义突变,可导致提前终止并产生截短体;mut2 的 CANT1 二聚体显著减少,甚至无法检测到。与野生型相比,mut1 的细胞外分泌极高,而 mut2 则显著减少。mut1 和 mut2 还可导致 CANT1 核苷酸酶活性显著降低。从结果可以推断,CANT1 基因的这两种突变是本研究中两个病例的原因。

结论

鉴于本研究报道的病例的特殊性,CANT1 的发病机制可能更为复杂。需要进一步研究具有相同遗传背景的 3 名儿童的遗传和表型。需要更大的患者队列来建立 DBQD 的基因型-表型相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc46/7487677/10e5900e2fb4/13023_2020_1492_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc46/7487677/58d214d63556/13023_2020_1492_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc46/7487677/a53fe638e825/13023_2020_1492_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc46/7487677/76fe94ff547a/13023_2020_1492_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc46/7487677/150a74909c88/13023_2020_1492_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc46/7487677/f4f0b79af966/13023_2020_1492_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc46/7487677/a20ccf267911/13023_2020_1492_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc46/7487677/142767aa3187/13023_2020_1492_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc46/7487677/0e1e2116dddf/13023_2020_1492_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc46/7487677/10e5900e2fb4/13023_2020_1492_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc46/7487677/58d214d63556/13023_2020_1492_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc46/7487677/a53fe638e825/13023_2020_1492_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc46/7487677/76fe94ff547a/13023_2020_1492_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc46/7487677/150a74909c88/13023_2020_1492_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc46/7487677/f4f0b79af966/13023_2020_1492_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc46/7487677/a20ccf267911/13023_2020_1492_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc46/7487677/142767aa3187/13023_2020_1492_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc46/7487677/0e1e2116dddf/13023_2020_1492_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cc46/7487677/10e5900e2fb4/13023_2020_1492_Fig9_HTML.jpg

相似文献

1
Cloning, expression and enzyme activity delineation of two novel CANT1 mutations: the disappearance of dimerization may indicate the change of protein conformation and even function.克隆、表达及酶活性分析两种新型 CANT1 突变:二聚化的缺失可能提示蛋白构象发生改变,甚至功能丧失。
Orphanet J Rare Dis. 2020 Sep 9;15(1):240. doi: 10.1186/s13023-020-01492-8.
2
A novel CANT1 mutation in three Indian patients with Desbuquois dysplasia Kim type.三名患有金氏型德斯布凯发育不全的印度患者中发现一种新的CANT1突变。
Eur J Med Genet. 2015 Feb;58(2):105-10. doi: 10.1016/j.ejmg.2014.11.006. Epub 2014 Dec 5.
3
A novel homozygous variant in causes Desbuquois dysplasia type 1 in a Chinese family and review of literatures.一个新的纯合变异导致一个中国家庭患1型德斯布瓦氏发育不良并文献复习
Int J Clin Exp Pathol. 2020 Aug 1;13(8):2137-2142. eCollection 2020.
4
A founder mutation of CANT1 common in Korean and Japanese Desbuquois dysplasia.韩国和日本德斯布瓦氏发育不良中常见的 CANT1 共同的创始突变。
J Hum Genet. 2011 May;56(5):398-400. doi: 10.1038/jhg.2011.28. Epub 2011 Mar 17.
5
CANT1 mutation is also responsible for Desbuquois dysplasia, type 2 and Kim variant.CANT1 突变也与 Desbuquois 发育不良 2 型和 Kim 变异型有关。
J Med Genet. 2011 Jan;48(1):32-7. doi: 10.1136/jmg.2010.080226. Epub 2010 Oct 30.
6
Further delineation of CANT1 phenotypic spectrum and demonstration of its role in proteoglycan synthesis.进一步描绘 CANT1 表型谱,并证明其在蛋白聚糖合成中的作用。
Hum Mutat. 2012 Aug;33(8):1261-6. doi: 10.1002/humu.22104. Epub 2012 May 22.
7
Antenatal Phenotype of Desbuquois Dysplasia.德斯布瓦氏发育不全的产前表型
Indian J Pediatr. 2023 Jan;90(1):83-86. doi: 10.1007/s12098-022-04386-8. Epub 2022 Nov 4.
8
Clinical and Genetic Insights into Desbuquois Dysplasia: Review of 111 Case Reports.德斯布夸斯发育不良的临床与遗传学研究:111 例病例报告综述。
Int J Mol Sci. 2024 Sep 7;25(17):9700. doi: 10.3390/ijms25179700.
9
XYLT1 mutations in Desbuquois dysplasia type 2.Desbuquois 发育不良 2 型中 XYLT1 突变。
Am J Hum Genet. 2014 Mar 6;94(3):405-14. doi: 10.1016/j.ajhg.2014.01.020. Epub 2014 Feb 27.
10
Endoplasmic reticulum retention of xylosyltransferase 1 (XYLT1) mutants underlying Desbuquois dysplasia type II.II型德斯布瓦氏发育不全相关的木糖基转移酶1(XYLT1)突变体在内质网的滞留
Am J Med Genet A. 2017 Jul;173(7):1773-1781. doi: 10.1002/ajmg.a.38244. Epub 2017 Apr 30.

引用本文的文献

1
Genetic Association of CANT1 Gene with Scoliosis: An Integrative Study Involving Methylation, Immune Factors, and Metabolites.CANT1基因与脊柱侧弯的遗传关联:一项涉及甲基化、免疫因子和代谢产物的综合研究。
J Mol Neurosci. 2025 Aug 7;75(3):100. doi: 10.1007/s12031-025-02383-y.
2
Cant1 Affects Cartilage Proteoglycan Properties: Aggrecan and Decorin Characterization in a Mouse Model of Desbuquois Dysplasia Type 1.Cant1 影响软骨蛋白聚糖特性:Desbuquois 发育不良 1 型小鼠模型中的聚集蛋白聚糖和核心蛋白聚糖的特征。
Biomolecules. 2024 Aug 26;14(9):1064. doi: 10.3390/biom14091064.
3
Clinical and Genetic Insights into Desbuquois Dysplasia: Review of 111 Case Reports.

本文引用的文献

1
[Analysis of CANT1 gene variant in a girl with Desbuquois dysplasia type I].[一名患有Ⅰ型德斯布瓦发育不全女童的CANT1基因变异分析]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2019 Dec 10;36(12):1206-1209. doi: 10.3760/cma.j.issn.1003-9406.2019.12.014.
2
Nosology and classification of genetic skeletal disorders: 2019 revision.遗传骨骼疾病的命名学和分类:2019 修订版。
Am J Med Genet A. 2019 Dec;179(12):2393-2419. doi: 10.1002/ajmg.a.61366. Epub 2019 Oct 21.
3
The PSIPRED Protein Analysis Workbench: 20 years on.PSIPRED 蛋白质分析工作平台:20 年的发展
德斯布夸斯发育不良的临床与遗传学研究:111 例病例报告综述。
Int J Mol Sci. 2024 Sep 7;25(17):9700. doi: 10.3390/ijms25179700.
4
Identification of a novel de novo mutation of SETBP1 and new findings of SETBP1 in tumorgenesis.鉴定一个新的 SETBP1 从头突变和 SETBP1 在肿瘤发生中的新发现。
Orphanet J Rare Dis. 2023 May 7;18(1):107. doi: 10.1186/s13023-023-02705-6.
5
METTL3-Mediated mA RNA Methylation of ZBTB4 Interferes With Trophoblast Invasion and Maybe Involved in RSA.METTL3介导的ZBTB4的m⁶A RNA甲基化干扰滋养层细胞侵袭并可能与复发性流产有关。
Front Cell Dev Biol. 2022 Jun 14;10:894810. doi: 10.3389/fcell.2022.894810. eCollection 2022.
Nucleic Acids Res. 2019 Jul 2;47(W1):W402-W407. doi: 10.1093/nar/gkz297.
4
Calcium activated nucleotidase 1 (CANT1) is critical for glycosaminoglycan biosynthesis in cartilage and endochondral ossification.钙激活核苷酸酶 1(CANT1)对于软骨和软骨内骨化中的糖胺聚糖生物合成至关重要。
Matrix Biol. 2019 Aug;81:70-90. doi: 10.1016/j.matbio.2018.11.002. Epub 2018 Nov 12.
5
Novel and recurrent XYLT1 mutations in two Turkish families with Desbuquois dysplasia, type 2.两个患有2型德斯布瓦氏发育不良的土耳其家庭中的新型和复发性XYLT1突变。
J Hum Genet. 2017 Mar;62(3):447-451. doi: 10.1038/jhg.2016.143. Epub 2016 Nov 24.
6
The Phyre2 web portal for protein modeling, prediction and analysis.用于蛋白质建模、预测和分析的Phyre2网络门户。
Nat Protoc. 2015 Jun;10(6):845-58. doi: 10.1038/nprot.2015.053. Epub 2015 May 7.
7
A novel CANT1 mutation in three Indian patients with Desbuquois dysplasia Kim type.三名患有金氏型德斯布凯发育不全的印度患者中发现一种新的CANT1突变。
Eur J Med Genet. 2015 Feb;58(2):105-10. doi: 10.1016/j.ejmg.2014.11.006. Epub 2014 Dec 5.
8
Case of Desbuquois dysplasia type 1: potentially lethal skeletal dysplasia.1型德斯布瓦氏发育不全病例:潜在致命性骨骼发育不良。
Pediatr Int. 2014 Aug;56(4):e26-9. doi: 10.1111/ped.12383.
9
XYLT1 mutations in Desbuquois dysplasia type 2.Desbuquois 发育不良 2 型中 XYLT1 突变。
Am J Hum Genet. 2014 Mar 6;94(3):405-14. doi: 10.1016/j.ajhg.2014.01.020. Epub 2014 Feb 27.
10
Further delineation of CANT1 phenotypic spectrum and demonstration of its role in proteoglycan synthesis.进一步描绘 CANT1 表型谱,并证明其在蛋白聚糖合成中的作用。
Hum Mutat. 2012 Aug;33(8):1261-6. doi: 10.1002/humu.22104. Epub 2012 May 22.